The Anaphylaxis market report covers emerging drugs, current treatment practices, market share of the individual therapies, current and forecasted market size from 2019 to 2032. It evaluates the current treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market.
Anaphylaxis: An Overview
Anaphylaxis is an acute, potentially life-threatening, generalized, or systemic allergic reaction that is mediated by the degranulation of mast cells and basophils. The condition usually develops suddenly and gets worse very quickly. The symptoms include feeling lightheaded or faint, breathing difficulties – such as fast, shallow breathing, wheezing, fast heartbeat, clammy skin, confusion, anxiety, collapsing, or losing consciousness.
Anaphylaxis is the result of the immune system, overreacting to a trigger. Common anaphylaxis triggers include foods (like nuts, milk, fish, shellfish, eggs, and some fruits), medicines (some antibiotics and non-steroidal anti-inflammatory drugs (NSAIDs) like aspirin), insect stings (particularly wasp and bee stings), general anesthetic, contrast agents (like dyes used in some medical tests to help certain areas of the body show up better on scans), latex and others. In some cases, there is no obvious trigger. This is known as idiopathic anaphylaxis.
The pipeline of Anaphylaxis possesses potential key players, such as Aquestive Therapeutics, Wyss Institute, and others. The dynamics of the Anaphylaxis market is anticipated to change in the coming years owing to the improvement in the research and development activities so that market will comprise efficient treatment options. The launch of emerging therapies is expected during the forecast period.
Anaphylaxis Market Key Facts
-
As per the study conducted by Yu et al. (2018), titled “The Epidemiology of Anaphylaxis”, wherein the lifetime prevalence of anaphylaxis was estimated at 0.05–2% in the USA and approximately 3% in Europe.
-
National Institute For Health And Care Excellence (NICE) (2015), stated that between March 2013 and February 2014 approximately 1 in 5 admissions to hospitals in England due to allergies were for an anaphylactic reaction (4070 out of 20,318). This was an increase of 9.9% in the same period in the previous year.
-
According to a review by Shaker et al., (2020) titled “Anaphylaxis—a 2020 practice parameter update, systematic review, and Grading of Recommendations, Assessment, Development and Evaluation (GRADE) analysis”, the lifetime prevalence of anaphylaxis has been estimated at 1.6% to 5.1%.
The market outlook section of the report helps to build a detailed comprehension of the historic, current, and forecasted Anaphylaxis market size and share by analyzing the impact of current and emerging therapies on the market. It also provides a detailed assessment of the unmet needs, market drivers barriers, and emerging technologies.
The report gives a thorough detail of the Anaphylaxis market trend for each marketed drug and late-stage pipeline therapies by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action (MoA), competition with other therapies, brand value, their impact on the market and view of the key opinion leaders.
Anaphylaxis Epidemiology
The epidemiology section covers insights about the historical and current Anaphylaxis patient pool and forecasted trends for every seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends along with assumptions undertaken.
Anaphylaxis Epidemiology Segmentation
-
Prevalent Population of Anaphylaxis
-
Diagnosed and Treatable Cases of Anaphylaxis
-
Trigger-specific Population of Anaphylaxis (Food, Medications, and others)
Anaphylaxis Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Anaphylaxis market or expected to get launched in the market during the study period. The analysis covers Anaphylaxis market uptake by drugs; patient uptake by therapies; and sales of each drug.
Report’s Drugs Uptake section helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.
The report also covers the Anaphylaxis Pipeline Development Activities and provides valuable insights about different therapeutic candidates in Phase II, and Phase III stages and the key companies in the market involved in developing targeted therapeutics. It also analyses the recent Development such as collaborations, acquisitions, and mergers, licensing patent details, and other information for emerging therapies.
Anaphylaxis Therapeutics Analysis
Some of the key companies in the Anaphylaxis Market include:
-
Aquestive Therapeutics
-
Wyss Institute
And others.
Get the PDF Sample of the Report:- Anaphylaxis Therapeutics Market
Anaphylaxis Therapies covered in the report include:
-
AQST-108
-
AQST-109
-
AbbieSense technology
And many more
As the current market of Anaphylaxis is dominated by epinephrine and its various auto-injectors along with their generics, there is a major unmet need for therapies with novel mechanisms of action that can change the current market scenario. Moreover, the indication has various other unmet needs.
Get More Detailed Insights into the Emerging Therapies & Key Companies:- Chronic Insomnia Therapeutics Landscape
Table of Content
1. Key Insights
2. Executive Summary
3. Anaphylaxis Competitive Intelligence Analysis
4. Anaphylaxis Market Overview at a Glance
5. Anaphylaxis Disease Background and Overview
6. Anaphylaxis Patient Journey
7. Anaphylaxis Epidemiology and Patient Population
8. Anaphylaxis Treatment Algorithm, Current Treatment, and Medical Practices
9. Anaphylaxis Unmet Needs
10. Key Endpoints of Anaphylaxis Treatment
11. Anaphylaxis Marketed Products
12. Anaphylaxis Emerging Therapies
13. Anaphylaxis Seven Major Market Analysis
14. Attribute Analysis
15. Anaphylaxis Market Outlook (7 major markets)
16. Anaphylaxis Access and Reimbursement Overview
17. KOL Views on the Anaphylaxis Market.
18. Anaphylaxis Market Drivers
19. Anaphylaxis Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
*The table of contents is not exhaustive; the final content may vary.
Request Sample Report here:- https://www.delveinsight.com/report-store/anaphylaxis-market
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email:Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/report-store/malignant-mesothelioma-market
